None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Adults with a BMI between 18.5 and less than 35 kg/m² (ranging from normal weight to the pre–severe obesity stage) - Able to provide blood, urine, stool, and saliva samples - No objection to wearing a continuous glucose monitoring device for more than 10 days on a soft, non-muscular area on the back of either upper arm
Exclusion criteria
Exclusion criteria: - Women who are pregnant or breastfeeding - Individuals with specific food allergies - Individuals with skin inflammation or dermatological conditions - Individuals scheduled to undergo medical procedures involving strong magnetic or electromagnetic radiation during the study period (e.g., X-ray, MRI, CT scan) - Patients with glucose–galactose malabsorption or diabetes insipidus - Patients with hypersensitivity or a history of allergy to Sunset Yellow FCF (Yellow No. 5) or Tartrazine (Yellow No. 4) - Individuals who have taken antibiotics within the past 3 months - Individuals with high-risk drinking habits or diagnosed with alcohol dependence within the past 3 months - Individuals with a body weight change of =10% within the past 3 months, or currently following a controlled diet for weight management - Individuals who have participated in another clinical trial within the past 3 months involving administration of an investigational product or dietary intervention - Individuals requiring dietary restrictions due to diseases such as diabetes, hypertension, cardiovascular disease, kidney disease, gastrointestinal disease, fatty liver, or thyroid disorders - Individuals requiring continuous blood glucose management or currently receiving pharmacological treatment such as antidiabetic drugs or insulin - Individuals taking medications that may affect body weight - Individuals presenting with acute illness (e.g., fever) at the set-up visit or baseline visit (study start date) - Individuals with a history of major gastrointestinal surgery (except cholecystectomy or appendectomy) or bowel resection within the past 6 months - Individuals with uncontrolled active gastrointestinal diseases or disorders - Individuals with a history of cardiovascular diseases (e.g., heart failure, myocardial infarction, stroke), renal diseases (e.g., chronic kidney failure, nephrotic syndrome), pulmonary diseases (e.g., asthma, chronic obstructive pulmonary disease), or hepatitis B or C - Individuals with a history of cancer, except for localized resected squamous cell carcinoma or basal cell carcinoma of the skin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postprandial glucose response following the test meal | — |
Secondary
| Measure | Time frame |
|---|---|
| Gut microbiome composition | — |
Countries
Korea, Republic of
Contacts
Korea Food Research Institute